Sort
30,917 grants matching “tumor microenvironment”
MOSAIC: Imaging Human Tissue State Dynamics In Vivo
$325,756Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2024 · CA
Microenvironment mediated drug resistance in melanoma.
$325,734Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS
$325,732Romi Gupta · University Of Alabama At Birmingham · R01 · FY2025 · CA
PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS
$325,732Romi Gupta · University Of Alabama At Birmingham · R01 · FY2021 · CA
CSF1 signaling in gliomagenesis
$325,726Lara S Collier · University Of Wisconsin-Madison · R01 · FY2019 · NS
High-speed/resolution whole slide scanner supported by two core facilities
$325,700John S Condeelis · Albert Einstein College Of Medicine · S10 · FY2015 · OD
Neurofibromatosis type 1 Gene Regulates Myelopoiesis
$325,689David W. Clapp · Indiana University Indianapolis · R01 · FY2009 · CA
Cancer and Stroma-Targeted Immunotherapy with a Gentically Modified DC Vaccine
$325,652Xiaotong Song · Baylor College Of Medicine · R01 · FY2015 · CA
Novel Target(s) in the Radiosensitization of Pancreatic Cancer
$325,622Surinder Kumar Batra · University Of Nebraska Medical Center · P50 · FY2015 · CA
RhoH GTPase in Hematopoiesis and Cancer
$325,549David A Williams · Boston Children'S Hospital · R01 · FY2012 · CA
Molecular Targeted Radionuclide Therapy with Tumor-Specific Vaccine to Stimulate and Expand T-cell Activation
$325,547Douglas G McNeel · University Of Wisconsin-Madison · P01 · FY2021 · CA
Neuroimmunomodulation within the eye
$325,500Schepens Eye Research Institute · R01 · FY2005 · EY
Neuroimmunomodulation within the eye
$325,500Schepens Eye Research Institute · R01 · FY2004 · EY
Neuroimmunomodulation within the eye
$325,500Schepens Eye Research Institute · R01 · FY2003 · EY
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
$325,459Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Mining B-catenin/BCL9 transcriptional complex for Multiple Myeloma therapeutics
$325,422Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Core 2: Ecological Core
$325,419Joel Brown · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA
Novel Immunotherapy of Glioma using miR-17-92 Transfected T Cells
$325,402Hideho Okada · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · NS
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
$325,384Metin Nafi Gurcan · Ohio State University · R01 · FY2014 · CA
Cellular diversity and clinical relevance of stem cells in pancreatic cancer
$325,377William H Matsui · Johns Hopkins University · R01 · FY2014 · CA
Sten Cell Gene Therapy of Breast Cancer
$325,237Andre Michael Lieber · University Of Washington · R01 · FY2010 · CA
Novel Immunotherapy of Glioma using miR-17-92 Transfected T Cells
$325,222Hideho Okada · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · NS
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
$325,183Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2014 · CA
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
$325,181Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2016 · CA
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
$325,181Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2015 · CA